Literature DB >> 22887894

Alcohol and drugs in seriously injured drivers in six European countries.

Sara-Ann Legrand1, Cristina Isalberti, Trudy Van der Linden, Inger Marie Bernhoft, Tove Hels, Kirsten Wiese Simonsen, Donata Favretto, Santo Davide Ferrara, Marija Caplinskiene, Zita Minkuviene, Alvydas Pauliukevicius, Sjoerd Houwing, René Mathijssen, Pirjo Lillsunde, Kaarina Langel, Tom Blencowe, Alain G Verstraete.   

Abstract

The objective of this study was to determine the presence of alcohol and drugs in drivers severely injured in traffic crashes in six European countries. Data were collected from 2492 seriously injured drivers of cars and vans in Belgium, Denmark, Finland, Italy, Lithuania, and the Netherlands, between 2007 and 2010. Toxicological analysis was performed with chromatographic techniques on whole blood for 23 substances. The percentage of drivers positive for at least one psychoactive substance ranged between 28% (Lithuania) and 53% (Belgium). Alcohol (≥0.1 g/L) was the most common finding with the highest percentage in Belgium (42.5%). Among the alcohol-positive drivers, 90.5% had a blood alcohol count (BAC) ≥0.5 g/L and 65.7% had a BAC ≥1.3 g/L. Benzodiazepines (0.0-10.2%) and medicinal opioids (0.5-7.8%) were the most prevailing medicinal drugs, but half of the concentrations were lower than therapeutic. Cannabis (0.5-7.6%) was the most prevailing illicit drug. Alcohol was found in combination with drugs in 2.3-13.2% of the drivers. Drug combinations were found in 0.5-4.3% of the drivers. This study confirms the high prevalence of psychoactive substances in injured drivers, but we observed large differences between the participating countries. Alcohol was the most common finding, followed by cannabis and benzodiazepines. Notable are the many drivers having a BAC ≥ 1.3 g/L. The majority of the substances were found in combination with another psychoactive substance, mostly alcohol. The high prevalence of high BACs and combinations (compared to roadside surveys) suggest that those drivers are most at risk and that preventive actions should target them preferentially.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22887894     DOI: 10.1002/dta.1393

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  6 in total

1.  Cannabis effects on driving lateral control with and without alcohol.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; Russell S Pierce; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2015-06-23       Impact factor: 4.492

Review 2.  Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases.

Authors:  Mary-Ann Fitzcharles; Winfried Häuser
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

3.  Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies.

Authors:  Yusuf S Althobaiti; Youssef Sari
Journal:  J Addict Res Ther       Date:  2016-06-11

4.  Investment in roads and traffic safety: linked to economic development? A European comparison.

Authors:  José Navarro-Moreno; Francisco Calvo-Poyo; Juan de Oña
Journal:  Environ Sci Pollut Res Int       Date:  2022-08-22       Impact factor: 5.190

5.  Potential for cannabis adaptation among participants in a drunk driving intervention.

Authors:  Michael Scherer; Paul Marques; Amy R Manning; Thomas H Nochajski; Eduardo Romano; Eileen Taylor; Robert Voas; Sagan King
Journal:  J Subst Use       Date:  2020-04-08

Review 6.  Driving under the influence of drugs: Correlation between blood psychoactive drug concentrations and cognitive impairment. A narrative review taking into account forensic issues.

Authors:  Alberto Blandino; Rosy Cotroneo; Stefano Tambuzzi; Domenico Di Candia; Umberto Genovese; Riccardo Zoja
Journal:  Forensic Sci Int Synerg       Date:  2022-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.